Enservco Corporation Common Stock (ENSV)
0.1452
+0.00 (0.00%)
NYSE · Last Trade: Apr 6th, 12:32 AM EDT

ENSV stock results show that Enservco beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

Via Benzinga · June 14, 2024

Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Via InvestorPlace · June 14, 2024

Via Benzinga · June 10, 2024

ENSV stock results show that Enservco beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definiti
Via Benzinga · April 16, 2024

ENSV stock results show that Enservco missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
Via Benzinga · April 1, 2024

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
Via InvestorPlace · April 3, 2023

Gainers
Via Benzinga · February 23, 2023

Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards.
Via InvestorPlace · January 13, 2023

In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10.
Via InvestorPlace · January 3, 2023

U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday.
Via Benzinga · October 24, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
Via Benzinga · November 1, 2022

Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability and immunogenicity of VAX-24.
Via Benzinga · October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via Benzinga · October 24, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.
Via Benzinga · October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via Benzinga · October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via Benzinga · October 20, 2022